TSCAN THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
TSCAN THERAPEUTICS, INC. (TCRX) reported Basic Shares Outstanding (Weighted Average) of 129.95 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- TSCAN THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 129.95M shares, a 0.17% increase year-over-year.
- TSCAN THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 129.91M shares, a 0.18% increase year-over-year.
- TSCAN THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 129.86M shares, a 7.45% increase year-over-year.
- TSCAN THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 129.84M shares, a 9.38% increase year-over-year.
- TSCAN THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 129.78M shares, a 15.88% increase from fiscal 2024.
- TSCAN THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 111.99M shares, a 70.72% increase from fiscal 2023.
- TSCAN THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 65.60M shares, a 172.78% increase from fiscal 2022.
- TSCAN THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 24.05M shares, a 106.20% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 129.95M shares 10-Q · filed 2026-08-12 | 129.93M shares 10-Q · filed 2026-08-12 | 129.91M shares derived: average of 3 quarters · filed 2026-08-12 | 129.89M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 129.91M shares 10-Q · filed 2026-05-06 | 129.89M shares derived: average of 2 quarters · filed 2026-05-06 | 129.87M shares derived: average of 3 quarters · filed 2026-05-06 | 129.84M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 129.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 129.85M shares derived: average of 2 quarters · filed 2026-03-04 | 129.81M shares derived: average of 3 quarters · filed 2026-08-12 | 129.78M shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 129.84M shares 10-Q · filed 2025-11-12 | 129.78M shares derived: average of 2 quarters · filed 2026-08-12 | 129.75M shares 10-Q · filed 2025-11-12 | 127.52M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 129.73M shares 10-Q · filed 2026-08-12 | 129.70M shares 10-Q · filed 2026-08-12 | 126.75M shares derived: average of 3 quarters · filed 2026-08-12 | 124.74M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 129.68M shares 10-Q · filed 2026-05-06 | 125.27M shares derived: average of 2 quarters · filed 2026-05-06 | 123.08M shares derived: average of 3 quarters · filed 2026-05-06 | 120.66M shares derived: average of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | 120.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 119.78M shares derived: average of 2 quarters · filed 2026-03-04 | 117.66M shares derived: average of 3 quarters · filed 2026-03-04 | 111.99M shares 10-K · filed 2026-03-04 |
| 2024-09-30 | 118.70M shares 10-Q · filed 2025-11-12 | 116.06M shares derived: average of 2 quarters · filed 2025-11-12 | 109.04M shares 10-Q · filed 2025-11-12 | 105.57M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 113.43M shares 10-Q · filed 2025-08-12 | 104.15M shares 10-Q · filed 2025-08-12 | 101.19M shares derived: average of 3 quarters · filed 2025-08-12 | 99.60M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 94.88M shares 10-Q · filed 2025-05-06 | 95.07M shares derived: average of 2 quarters · filed 2025-05-06 | 94.99M shares derived: average of 3 quarters · filed 2025-05-06 | 83.05M shares derived: average of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | 95.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | 95.05M shares derived: average of 2 quarters · filed 2025-03-05 | 79.10M shares derived: average of 3 quarters · filed 2025-03-05 | 65.60M shares 10-K · filed 2025-03-05 |
| 2023-09-30 | 94.83M shares 10-Q · filed 2024-11-12 | 71.02M shares derived: average of 2 quarters · filed 2024-11-12 | 55.71M shares 10-Q · filed 2024-11-12 | 47.59M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 47.21M shares 10-Q · filed 2024-08-12 | 35.72M shares 10-Q · filed 2024-08-12 | 31.84M shares derived: average of 3 quarters · filed 2024-08-12 | 29.90M shares derived: average of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | 24.23M shares 10-Q · filed 2024-05-13 | 24.15M shares derived: average of 2 quarters · filed 2024-05-13 | 24.13M shares derived: average of 3 quarters · filed 2024-05-13 | 24.11M shares derived: average of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | 24.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | 24.08M shares derived: average of 2 quarters · filed 2024-03-06 | 24.07M shares derived: average of 3 quarters · filed 2024-03-06 | 24.05M shares 10-K · filed 2024-03-06 |
| 2022-09-30 | 24.07M shares 10-Q · filed 2023-11-09 | 24.07M shares derived: average of 2 quarters · filed 2023-11-09 | 24.04M shares 10-Q · filed 2023-11-09 | 24.02M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 24.06M shares 10-Q · filed 2023-08-10 | 24.02M shares 10-Q · filed 2023-08-10 | 24.00M shares derived: average of 3 quarters · filed 2023-08-10 | 22.97M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 23.97M shares 10-Q · filed 2023-05-10 | 23.97M shares derived: average of 2 quarters · filed 2023-05-10 | 22.60M shares derived: average of 3 quarters · filed 2023-05-10 | 17.30M shares derived: average of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | 23.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | 21.92M shares derived: average of 2 quarters · filed 2023-03-08 | 15.08M shares derived: average of 3 quarters · filed 2023-03-08 | 11.66M shares 10-K · filed 2023-03-08 |
| 2021-09-30 | 19.88M shares 10-Q · filed 2022-11-09 | 10.63M shares derived: average of 2 quarters · filed 2022-11-09 | 7.56M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 1.39M shares 10-Q · filed 2022-08-10 | 1.30M shares 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |